Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04276688
What this trial is testing

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

Who this might be right for
Novel Coronavirus Infection
The University of Hong Kong 127
Not applicableStudy completedNCT00252642
What this trial is testing

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

Who this might be right for
Hepatitis CCirrhosisFibrosis
Virginia Commonwealth University 60
Early research (Phase 1)Study completedNCT00970996
What this trial is testing

Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 10
Large-scale testing (Phase 3)Study completedNCT03710876
What this trial is testing

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ferring Ventures Limited 53
Large-scale testing (Phase 3)Study completedNCT00140569
What this trial is testing

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Who this might be right for
Follicular Lymphoma
Lymphoma Study Association 400
Testing effectiveness (Phase 2)Study completedNCT01011166
What this trial is testing

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 81
Not applicableUnknownNCT02057003
What this trial is testing

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Who this might be right for
Hepatitis C, ChronicHuman Immunodeficiency Virus
Valme University Hospital 1,000
Not applicableUnknownNCT00563095
What this trial is testing

A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Hospital Authority, Hong Kong 100
Large-scale testing (Phase 3)Study completedNCT01297270
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 658
Not applicableUnknownNCT04943679
What this trial is testing

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 15
Large-scale testing (Phase 3)Study completedNCT01359956
What this trial is testing

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

Who this might be right for
Malignant MelanomaRecurrent Melanoma
National Cancer Institute, Naples 269
Testing effectiveness (Phase 2)Ended earlyNCT01866553
What this trial is testing

Nilotinib Plus Pegylated Interferon-α2b in CML

Who this might be right for
Chronic Myeloid Leukemia
Amsterdam UMC, location VUmc 20
Large-scale testing (Phase 3)Study completedNCT00441103
What this trial is testing

Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 180
Large-scale testing (Phase 3)Study completedNCT02219503
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie 60
Testing effectiveness (Phase 2)Looking for participantsNCT07069569
What this trial is testing

Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 200
Post-approval studies (Phase 4)Ended earlyNCT00641654
What this trial is testing

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
Göteborg University 75
Large-scale testing (Phase 3)Study completedNCT00205751
What this trial is testing

Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 350
Large-scale testing (Phase 3)Study completedNCT00883337
What this trial is testing

A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 324
Not applicableUnknownNCT00449345
What this trial is testing

Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis

Who this might be right for
Latent Tuberculosis Infection
Assuta Hospital Systems 150
Not applicableLooking for participantsNCT06762002
What this trial is testing

Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

Who this might be right for
ImmunologyAllergyGenetic Diseases+1 more
Institut National de la Santé Et de la Recherche Médicale, France 500
Next Page